177
Participants
Start Date
July 13, 2018
Primary Completion Date
February 21, 2020
Study Completion Date
February 21, 2020
Azithromycin
Azithromycin monohydrate is a macrolide antibacterial drug, FDA-approved in the US for the treatment of Chlamydia trachomatis (CT) in dose 1 gram (4 capsules of 250 mg), administered orally as a single dose.
Doxycycline
Doxycycline hyclate is an antibacterial drug synthetically derived from oxytetracycline, FDA-approved in the US for the treatment of Chlamydia trachomatis (CT) as a course of 100 mg (1 capsule), administered orally twice daily for 7 days.
Placebo
Azithromycin placebo (4 capsules), administered orally as a single dose; Doxycycline placebo (1 capsule), administered orally twice daily for 7 days.
Fenway Health - The Fenway Institute, Boston
University of Washington - Harborview Medical Center - Center for AIDS and STD, Seattle
National Institute of Allergy and Infectious Diseases (NIAID)
NIH